436 related articles for article (PubMed ID: 15715560)
21. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
22. Improved visual acuity and macular thickness 1 week after intravitreal triamcinolone for diabetic macular oedema.
Islam MS; Negi A; Vernon SA
Eye (Lond); 2005 Dec; 19(12):1325-7. PubMed ID: 15578081
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Ozkiris A; Evereklioglu C; Erkilic K; Dogan H
Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039
[TBL] [Abstract][Full Text] [Related]
24. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
Ozdemir H; Karacorlu M; Karacorlu SA
Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Ozdemir H; Karacorlu M; Karacorlu S
Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
Grenga P; Lupo S; Domanico D; Vingolo EM
Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
30. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.
Bakri SJ; Shah A; Falk NS; Beer PM
Eye (Lond); 2005 Jun; 19(6):686-8. PubMed ID: 15332099
[TBL] [Abstract][Full Text] [Related]
34. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.
Ockrim ZK; Sivaprasad S; Falk S; Roghani S; Bunce C; Gregor Z; Hykin P
Br J Ophthalmol; 2008 Jun; 92(6):795-9. PubMed ID: 18420749
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Chen SD; Sundaram V; Lochhead J; Patel CK
Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
[TBL] [Abstract][Full Text] [Related]
37. Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
Kawaji T; Takano A; Inomata Y; Sagara N; Iwao K; Inatani M; Fukushima M; Tanihara H
Br J Ophthalmol; 2008 Jan; 92(1):81-3. PubMed ID: 17965103
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
Margolis R; Singh RP; Bhatnagar P; Kaiser PK
Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
